
Neupro — rotigotine 4 mg/24 h, transdermal patch, 28 pcs
Brand: UCB
+ delivery from €40
Neupro. Active ingredient — rotigotine, 4 mg. Dosage form — matrix-type transdermal patch. Pack size — 28 transdermal patches.
Key information
Full description
Neupro 4 mg/24 h — a rotigotine transdermal patch; marketing authorisation holder UCB Pharma S.A., Belgium. The matrix-type patch releases the active ingredient through the skin. Rotigotine is a dopamine agonist intended for diseases associated with impaired dopaminergic transmission, including Parkinson's disease and restless legs syndrome, in accordance with the official package leaflet. Each patch releases 4 mg of rotigotine over 24 hours; the active ingredient content is 9.0 mg. The pack includes 28 patches. The backing layer contains aluminium, so the patch is removed before an MRI or cardioversion. Check the official package leaflet before use.
Administration
For transdermal use.
Storage conditions
Store at a temperature not exceeding 30 °C in the original package, out of the reach of children. Follow the storage conditions specified by the manufacturer.
Frequently asked questions
What is the active ingredient in Neupro?
Neupro contains rotigotine.
What dosage form is Neupro available in?
Dosage form: Matrix-type transdermal patch. Strength: 4 mg.
How much does a pack of Neupro contain?
The pack shown contains 28 transdermal patches.
How should Neupro be stored?
Store at a temperature not exceeding 30 °C in the original package, out of the reach of children. Follow the storage conditions specified by the manufacturer.
Other strengths and pack sizes
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.